First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...

Redefining hydrophilic coatings solutions by uniting advanced chemistry, device engineering and customer-first ...

Global Healthcare Asset Management Market OutlookThe global healthcare asset management market is poised for remarkable ...

Global Medical Adhesive Tapes Market OverviewThe global medical adhesive tapes market is anticipated to grow at a CAGR of approximately 6% during the forecast period, supported by a combination of ...

Critical Manufacturing, a leading provider of next-generation Manufacturing Execution Systems (MES) and a subsidiary of ASMPT, today announced a major appointment. Paul Straeten, a digital ...

Veteran medical oncologist with a proven track record of advancing cancer therapies from early trials through regulatory approval to lead ongoing clinical development of ALTA2618 and ALTA3263SAN DIEGO ...

Search Committee Has Initiated a Global Search to Select Next CEOLAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic ...

POTOMAC, MARYLAND / ACCESS Newswire / February 2, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), today reported it has reached approximately 70% of planned patient enrollment in ...

Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trialMAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

STOCKHOLM, SE / ACCESS Newswire / February 2, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, ...

Fourth quarter revenue of $772 million; 6% revenue growth; 4% organic growthFourth quarter GAAP EPS of $0.87; Adjusted EPS from continuing operations of $1.70Initiates full year 2026 guidanceWALTHAM, ...